JENNA BOYNE: Open Payments
NPI 1558910422 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,675 in 136 payments from 15 companies in 2025. Trend: 2023 $14 · 2024 $4,135 · 2025 $2,675
Food & beverage: $2,605Education: $70
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $438 |
| UCB, Inc. | 19 | $420 |
| Janssen Biotech, Inc. | 17 | $390 |
| Regeneron Healthcare Solutions, Inc. | 19 | $382 |
| Amgen Inc. | 10 | $185 |
| Incyte Corporation | 8 | $178 |
| Novartis Pharmaceuticals Corporation | 8 | $145 |
| Lilly USA, LLC | 7 | $135 |
| Organon LLC | 8 | $111 |
| LEO Pharma Inc. | 3 | $86 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, OTEZLA, RINVOQ, OPZELURA, COSENTYX.
Industry payments across OH — which companies pay providers there.
